血管质量倡议慢性肢体威胁性缺血死亡预测模型在远端旁路患者中的有效性
单中心回顾性分析2009至2020年因慢性肢体威胁性缺血行远端旁路的230例患者(287次旁路),按血管质量倡议慢性肢体威胁性缺血模型分为低、中、高危三组。低危组2年生存率81%显著高于中危组41%和高危组46%(均P<0.001),中危与高危组间无显著差异(P=0.81);低危组2年保肢率93%显著高于中危组81%(P=0.023)和高危组87%(P=0.039)。作者认为远端旁路是低危患者的最佳治疗,中高危患者决策需审慎考虑。
要点
- 低危组2年生存率81%显著高于中危组41%和高危组46%(均P<0.001)。
- 中危组与高危组2年生存率无显著差异(P=0.81)。
- 低危组2年保肢率93%显著高于中危组81%(P=0.023)和高危组87%(P=0.039)。
核心结论
- 结果表明远端旁路是血管质量倡议预测死亡低危患者的最佳治疗。
- 中危和高危患者2年保肢率较低、死亡率较高,提示其决策可能需要审慎考虑。
研究设计与样本
- 单中心回顾性研究,纳入2009至2020年因慢性肢体威胁性缺血行远端旁路的患者。
- 远端旁路定义为远端吻合至胫后动脉、胫前动脉、足背动脉、足底动脉或腓动脉的旁路。
- 共230例患者(153例男性;中位年龄74岁;糖尿病70%;终末期肾病伴血液透析38%)行287次远端旁路。
- 按血管质量倡议慢性肢体威胁性缺血模型分为低危153例(66%)、中危35例(15%)、高危42例(18%)。
- 主要终点为生存率和保肢率。
主要发现
- 30天内院内死亡2例(1%)。
- 平均随访33±29个月期间,105例患者死亡,26条肢体(9%)需大截肢。
- 低危组2年生存率81%显著高于中危组41%和高危组46%(均P<0.001)。
- 中危组与高危组2年生存率无显著差异(P=0.81)。
- 低危组2年保肢率93%显著高于中危组81%(P=0.023)和高危组87%(P=0.039)。
临床怎么用
- 作者认为远端旁路是血管质量倡议预测死亡低危患者的最佳治疗。
- 作者指出中危和高危患者2年保肢率较低、死亡率较高,其决策可能需要审慎考虑。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study is to evaluate the effectiveness of mortality prediction using the Vascular Quality Initiative (VQI) chronic limb-threatening ischemia (CLTI) model in patients with distal bypass. METHODS: Patients who underwent distal bypass for CLTI from 2009 to 2020 at a single center were retrospectively reviewed. Distal bypass was defined as any bypass with a distal anastomosis to the posterior tibial, anterior tibial, dorsalis pedis, plantar, or peroneal artery. Baseline characteristics, operative details, hospital outcomes, and medium-term outcomes were compared among patients with a low-, medium-, and high-risk of mortality based on a VQI CLTI calculation. The primary endpoints were survival and limb salvage. RESULTS: A total of 287 distal bypasses were performed in 230 patients (153 males; median age, 74 years; diabetes mellitus, 70%; end-stage renal disease [ESRD] with hemodialysis, 38%). These patients were stratified into 153 (66%) low-, 35 (15%) medium-, and 42 (18%) high-risk cases based on the VQI CLTI model. There were two hospital deaths (1%) within 30 days. During a mean follow-up period of 33 ± 29 months, 105 patients died and 26 limbs (9%) required major amputation. The 2-year survival rate of 81% in the low-risk group was significantly higher than those of 41% in the medium-risk group and 46% in the high-risk group (both P < 0.001). The 2-year survival rates did not differ significantly between the medium- and high-risk groups (P = 0.81). The 2-year limb salvage rate of 93% in the low-risk group was significantly higher than those of 81% in the medium-risk (P = 0.023) and those of 87% in the high-risk (P = 0.039) groups. There were no significant differences in graft patency and wound healing among the three groups. CONCLUSIONS: These results suggest that distal bypass is optimal treatment for patients with a low VQI-predicted risk of mortality. However, the lower limb salvage and higher mortality rates at 2 years suggest that the decision-making for VQI medium- and high-risk patients may be carefully considered.
引用
- Kobayashi T, Hamamoto M, Okazaki T, et al. Effectiveness of the Vascular Quality Initiative Chronic Limb-Threatening Ischemia Mortality Prediction Model in Patents with Distal Bypass. Ann Vasc Surg. 2022. PMID: 36442707. doi:10.1016/j.avsg.2022.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。